Evidence map›Paper›PMID 33440718›Full record

ArticleInternational journal of molecular sciences2021

Genetic Variations in Prostaglandin E

Catarina Lopes, Carina Pereira, Mónica Farinha, Rui Medeiros, Mário Dinis-Ribeiro

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Catarina LopesMolecular Oncology and Viral Pathology Group, IPO Porto Research (CI-IPOP), Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.ORCID 0000-0003-0176-286X
Carina PereiraMolecular Oncology and Viral Pathology Group, IPO Porto Research (CI-IPOP), Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Mónica FarinhaPathology Department, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Rui MedeirosMolecular Oncology and Viral Pathology Group, IPO Porto Research (CI-IPOP), Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.ORCID 0000-0003-3010-8373
Mário Dinis-RibeiroCINTESIS-Center for Health Technology and Services Research, University of Porto, Rua Dr. Plácido da Costa, 4200-450 Porto, Portugal.
Instituto Português de Oncologia Francisco Gentil · PTUniversidade do Porto · PTPortuguese League Against Epilepsy · PT

Funding

Fundação para a Ciência e a Tecnologia SFRH/BPD/114803/2016Sociedade Portuguesa de Gastrenterologia Nº1/2016
6 · The paper itself

Abstract

The cyclooxygenase-2 (COX-2)/prostaglandin E

Indexed as

Biomarkers, TumorDisease SusceptibilityGenetic VariationSignal TransductionAgedAged, 80 and overAllelesCase-Control StudiesDinoprostoneEuropeFemaleGene FrequencyGenotypeHumansMaleRisk AssessmentBiomarkers, TumorDinoprostoneATP binding cassette subfamily C member 4gastric cancergenetic susceptibilityhydroxyprostaglandin dehydrogenase 15-(NAD)prostaglandin E2prostaglandin-endoperoxide synthase 2solute carrier organic anion transporter family member 2A1

Identifiers

PMID33440718
PMCPMC7827533
OpenAlexW3118961193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.